FILE PHOTO: A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken (Reuters) - AstraZeneca Plc <AZN.L> said on Friday it would sell commercial rights for ...
Cheplapharm will pay AstraZeneca a total of $400m in non-contingent consideration, of which the present value will be recognised as Other Operating Income upon completion of the transaction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback